Crossmark

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database

Crossref DOI link: https://doi.org/10.1080/2162402X.2020.1722022

Published Online: 2020-04-07

Published Print: 2020-01

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Scanvion, Quentin https://orcid.org/0000-0001-5865-1525
Béné, Johana

Gautier, Sophie

Grandvuillemin, Aurélie

Le Beller, Christine

Chenaf, Chouki

Etienne, Nicolas

Brousseau, Solenn

Cortot, Alexis B.

Mortier, Laurent

Staumont-Sallé, Delphine

Morschhauser, Franck

Forestier, Alexandra

Groh, Matthieu

Launay, David

Hachulla, Eric

Labalette, Myriam

Kahn, Jean-Emmanuel

Lefèvre, Guillaume
License Information

License valid from 2020-01-01
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=koni20

Publication History

Received: 2019-06-15

Revised: 2019-09-13

Accepted: 2019-10-27

Published: 2020-04-07

Document is current

Any future updates will be listed below